Business Description
OKYO Pharma Ltd
NAICS : 213114
ISIN : GG00BD3FV870
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.83 | |||||
Equity-to-Asset | -0.4 | |||||
Debt-to-Equity | -1.08 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -482.2 | |||||
3-Year EPS without NRI Growth Rate | -573.1 | |||||
3-Year FCF Growth Rate | -457.2 | |||||
3-Year Book Growth Rate | -41.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.14 | |||||
6-1 Month Momentum % | -36.36 | |||||
12-1 Month Momentum % | -71.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -73.4 | |||||
Shareholder Yield % | -18.97 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -7265.69 | |||||
ROA % | -353.01 | |||||
ROIC % | -1597.63 | |||||
ROC (Joel Greenblatt) % | -219783.33 | |||||
ROCE % | -7206.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.64 | |||||
EV-to-EBITDA | -3.64 | |||||
EV-to-FCF | -6.24 | |||||
Earnings Yield (Greenblatt) % | -27.47 | |||||
FCF Yield % | -15.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
OKYO Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | |||
EPS (TTM) (£) | -0.003 | ||
Beta | 0 | ||
Volatility % | 80.46 | ||
14-Day RSI | 0 | ||
14-Day ATR (£) | 0.003059 | ||
20-Day SMA (£) | 0 | ||
12-1 Month Momentum % | -71.43 | ||
52-Week Range (£) | 0.0135 - 0.085 | ||
Shares Outstanding (Mil) | 1,658.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OKYO Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OKYO Pharma Ltd Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
OKYO Pharma Ltd Frequently Asked Questions
What is OKYO Pharma Ltd(LSE:OKYO)'s stock price today?
When is next earnings date of OKYO Pharma Ltd(LSE:OKYO)?
Does OKYO Pharma Ltd(LSE:OKYO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |